NanoLogix, Inc. Files a Provisional Patent Application for Treatment of Leukemia

SHARON, PA -- (MARKET WIRE) -- March 13, 2007 -- NanoLogix, Inc. (PINKSHEETS: NNLX) announced today that it has filed a provisional patent application with the U.S. Patent Office entitled “A Hydrophobic Hydrocarbon Coated Filtering Device for the Induction of Apoptosis in Leukemic Cells and Related Methods of Treating a Patient.” This intellectual property application was filed by the Pittsburgh law firm of Eckert, Seamans, Cherin and Mellott, LLC. The invention describes a number of unique and innovative methods for killing leukemia cells outside of a patient’s body by dialyzing, irradiating and biothermically manipulating the cancer cells, thereby killing the leukemia cells extracorporeally in a relatively nontoxic manner.

MORE ON THIS TOPIC